Notice2026-00421
Proposed Data Collection Submitted for Public Comment and Recommendations
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 13, 2026
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other federal agencies the opportunity to comment on continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled National Disease Surveillance Program--II. Disease Summaries information collection. This collection is used to determine the prevalence of diseases and for the planning and evaluation of programs that prevent and control infectious disease.
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 8 (Tuesday, January 13, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 8 (Tuesday, January 13, 2026)]
[Notices]
[Pages 1322-1324]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-00421]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-26-0004; Docket No. CDC-2026-0003]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the general public and other
federal agencies the opportunity to comment on continuing information
collection, as required by the Paperwork Reduction Act of 1995. This
notice invites comment on a proposed information collection project
titled National Disease Surveillance Program--II. Disease Summaries
information collection. This collection is used to determine the
prevalence of diseases and for the planning and evaluation of programs
that prevent and control infectious disease.
DATES: CDC must receive written comments on or before March 16, 2026.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2026-
0003 by either of the following methods:
<bullet> Federal eRulemaking Portal: <a href="http://www.regulations.gov">www.regulations.gov</a>. Follow
the instructions for submitting comments.
[[Page 1323]]
<bullet> Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS H21-8, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to <a href="http://www.regulations.gov">www.regulations.gov</a>.
Please note: Submit all comments through the Federal eRulemaking
portal (<a href="http://www.regulations.gov">www.regulations.gov</a>) or by U.S. mail to the address listed
above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS H21-8, Atlanta, Georgia 30329; Telephone: 404-639-7570;
Email: <a href="/cdn-cgi/l/email-protection#f996949bb99a9d9ad79e968f"><span class="__cf_email__" data-cfemail="513e3c33113235327f363e27">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected;
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses; and
5. Assess information collection costs.
Proposed Project
National Disease Surveillance Program II Disease Summaries (OMB
Control No. 0920-0004, Exp. 4/30/2026)--Extension--National Center for
Immunization and Respiratory Diseases (NCIRD), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
CDC requests a three-year approval for the Extension of the
National Disease Surveillance Program II--Disease Summaries information
collection. As with previous approvals, these data are essential for
measuring trends in diseases, evaluating the effectiveness of current
preventive strategies, and determining the need to modify current
preventive measures. The following diseases are included in this
surveillance program: Influenza Virus, Caliciviruses, Respiratory and
Enteric Viruses, Enteroviruses, Adenoviruses, Arthropod-Borne Diseases
(Non-Human Data), and Pediatric Hepatitis of Unknown Etiology. This
Extension with minimal modifications includes 10 influenza forms,
Suspect Respiratory Virus Patient Form, Middle East Respiratory
Syndrome Coronavirus (MERS) Patient Under Investigation (PUI) Form,
Viral Gastroenteritis Outbreak Submission Form, National Respiratory
and Enteric Virus Surveillance System (NREVSS) Laboratory Assessment
and National Enterovirus Surveillance Report, National Adenovirus Type
Reporting System (NATRS) Form, Aggregate case counts of persons exposed
to Highly Pathogenic Avian Influenza (HPAI), Pediatric Hepatitis of
Unknown Etiology Medical Record Abstraction Form (CRF) and Pediatric
Hepatitis of Unknown Etiology Medical Record Abstraction short form
version, and Arthropod (Vector)-Borne Diseases (Non-Human Data). These
forms will have minor edits with no burden change from last OMB
approval. The data from these forms will enable rapid detection and
characterization of outbreaks of known pathogens, as well as potential
newly emerging viral pathogens.
CDC requests OMB approval for an estimated 27,458 annual burden
hours. There is no cost to respondents other than their time to
participate.
Estimated Annualized Burden Hours
--------------------------------------------------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hr) (in hr)
--------------------------------------------------------------------------------------------------------------------------------------------------------
Epidemiologist................................. Attachment E--WHO Collaborating center 47 52 10/60 407
for Influenza--Influenza Virus
Surveillance.
Epidemiologist................................. Attachment F--U.S. WHO Collaborating 113 1 10/60 19
Laboratories Influenza Testing Methods
Assessment.
Epidemiologist................................. Attachment H--US Outpatient Influenza- 1,800 52 10/60 15,600
like Illness Surveillance Network
(ILINet) Workfolder 55.20E.
Epidemiologist................................. Attachment J--Influenza-Associated 57 2 30/60 57
Pediatric Mortality--Case Report Form.
Epidemiologist................................. Attachment K--Human Infection with 57 2 30/60 57
Novel Influenza A Virus Case Report
Form.
Epidemiologist................................. Attachment M--Human Infection with 57 1 90/60 86
Novel Influenza A Virus Severe
Outcomes.
Epidemiologist................................. Attachment P--Novel Influenza A Virus 57 1 15/60 14
Case Screening Form.
Epidemiologist................................. Attachment T--Antiviral Resistant 57 3 30/60 86
Influenza Infection Case Report Form.
[[Page 1324]]
Epidemiologist................................. Attachment U--National Respiratory & 550 52 15/60 7150
Enteric Virus Surveillance System
(NREVSS) (55.83A, B, D) (electronic).
Epidemiologist................................. Attachment V--National Enterovirus 20 12 15/60 60
Surveillance Report: (CDC 55.9)
(electronic).
Epidemiologist................................. Attachment W--National Adenovirus Type 13 4 15/60 13
Reporting System (NATRS).
Epidemiologist................................. Attachment X--Middle East Respiratory 57 3 25/60 71
Syndrome (MERS) Patient Under
Investigation (PUI) Short Form.
Epidemiologist................................. Attachment Y--Viral Gastroenteritis 20 5 5/60 8
Outbreak Submission Form.
Epidemiologist................................. Attachment AA--Influenza Virus 57 52 5/60 247
(Electronic, Year Round), PHLIP_HL7
messaging Data Elements.
Epidemiologist................................. Attachment BB--Influenza virus 3 52 5/60 13
(electronic, year round) (PHIN-MS).
Epidemiologist................................. Attachment CC--Suspect Respiratory 10 5 30/60 25
Virus Patient Form.
Epidemiologist................................. Attachment EE, Aggregate counts of 52 52 10/60 451
persons exposed to Highly Pathogenic
Avian Influenza (HPAI).
Epidemiologist................................. Attachment FF, Pediatric Hepatitis of 52 4 15/60 52
Unknown Etiology Medical Record
Abstraction Short Form.
Epidemiologist................................. Attachment GG, Pediatric Hepatitis of 52 2 45/60 78
Unknown Etiology Medical Record
Abstraction Form (CRF).
Epidemiologist................................. Attachment HH, Arthropod (Vector)-Borne 57 52 60/60 2964
Diseases (Non-Human Data).
---------------------------------------------------------------
Total...................................... .............. .............. .............. 27,458
--------------------------------------------------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2026-00421 Filed 1-12-26; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 13, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.